Japan's Latest Daily Volume Ranking

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	PER	PBR	Yield	Market Cap	Liquidity
OncoTherapy Science 4564 TSE Growth	20	-1 -4.8%	31,564,900	ー	4.78	ー %	7.53B	Mid
Solasia Pharma 4597 TSE Growth	28	-1 -3.5%	26,657,300	ー	4.11	ー %	7.38B	Mid
JELLY BEANS 3070 TSE Growth	109	+3 +2.83%	25,984,200	59.8	1.86	ー %	8.62B	Slightly High
MAC HOUSE 7603 TSE Standard	221	+13 +6.25%	6,921,800	ー	1.56	ー %	5.69B	High
Wintest Corp 6721 TSE Standard	116	-9 -7.2%	4,145,100	ー	8.57	ー %	6.22B	High
MEDINET 2370 TSE Growth	31	0 ー%	3,655,100	ー	2.17	ー %	8.21B	Mid
Def consulting 4833 TSE Growth	97	+10 +11.5%	3,583,900	ー	1.98	ー %	6.64B	High
BrightPath Biotherapeutics 4594 TSE Growth	63	-2 -3.1%	3,037,500	ー	4.73	ー %	7.12B	Slightly High
Mipox 5381 TSE Standard	525	-81 -13%	2,925,900	13.2	0.86	1.90 %	7.59B	Slightly High
SystemSoft 7527 TSE Standard	63	-2 -3.1%	2,499,200	242.3	1.32	ー %	5.34B	Slightly High
NAKAMURA CHOUKOU 6166 TSE Growth	604	-78 -11%	2,400,800	663.7	6.66	ー %	6.66B	Slightly High
KOZO Holdings 9973 TSE Standard	29	0 ー%	2,258,100	ー	10.7	ー %	8.54B	Mid
Ledax 7602 TSE Standard	309	-30 -8.9%	2,174,400	26.1	1.42	0.97 %	7.45B	Mid
iFree Nikkei225 -2x Inverse 1366 TSE ETF	128	-1 -0.8%	1,726,583	ー	ー	ー %	6.41B	Slightly High
Nihon Seimitsu 7771 TSE Standard	302	+7 +2.37%	1,477,500	64.5	4.10	ー %	6.72B	Slightly High
TORICO 7138 TSE Growth	341	-23 -6.3%	1,438,000	ー	4.28	ー %	5.1B	High
ONO SOKKI 6858 TSE Standard L-Up	784	+100 +14.6%	1,293,300	10.2	0.50	3.83 %	9.56B	Mid
SymBio Pharma 4582 TSE Growth	86	-2 -2.3%	1,135,100	ー	3.86	ー %	5.12B	Mid
Chordia Therapeutics 190A TSE Growth	128	+6 +4.92%	1,072,500	ー	3.99	ー %	9.11B	Slightly High
WHY HOW DO COMPANY 3823 TSE Standard	54	-1 -1.8%	1,055,900	ー	4.04	ー %	7.1B	High

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels